Tiger Eye Capital’s Abbott ABT Stock Holding History

Tiger Eye Capital’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-16,400	Closed	-$1.5M	–	42
2020 Q2	$1.5M	Sell	16,400 -13,600	-45%	-$1.23M	0.36%	21
2020 Q1	$2.37M	Buy	+30,000	New	+$2.5M	0.79%	18

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tiger Eye Capital's ABT Position: Q3 2020 in Review

Tiger Eye Capital sold out of Abbott (ABT) in Q3 2020, closing a stake of 16,400 shares — an estimated $1.5M sold.

Tiger Eye Capital first reported a position in ABT in Q1 2020 and held it in 2 quarters. The position peaked at $2.37M in Q1 2020. 2,307 funds tracked by Wall St. Rank hold ABT as of Q3 2020.

Tiger Eye Capital reported no remaining Abbott position as of Q3 2020 after selling out during the quarter.
Tiger Eye Capital sold 16,400 Abbott shares in Q3 2020, an estimated $1.5M.
Tiger Eye Capital first reported a position in Abbott in Q1 2020 and held it in 2 quarters.
Tiger Eye Capital's Abbott position peaked at $2.37M in Q1 2020.
2,307 funds tracked by Wall St. Rank held Abbott as of Q3 2020.

Based on Tiger Eye Capital's 13F filing for Q3 2020, filed 13 Nov 2020.